Greatbatch closes Enpath Medical acquisition:
This article was originally published in Clinica
Implantable device component manufacturer Greatbatch has closed its acquisition of Enpath Medical, the percutaneous delivery systems specialist. Greatbatch paid $14.38 for each Enpath share, in a cash tender offer, which expired on June 11. This transaction sees Enpath (Plymouth, Minnesota) become an indirect, wholly-owned subsidiary of Greatbatch.